The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Open accessAbstract
The RV144 trial demonstrated 31% vaccine efficacy at preventing human immunodeficiency virus (HIV)-1 infection. Antibodies against the HIV-1 envelope variable loops 1 and 2 (Env V1 and V2) correlated inversely with infection risk. We proposed that vaccine-induced immune responses against V1/V2 would have a selective effect against, or sieve, HIV-1 breakthrough viruses. A total of 936 HIV-1 genome sequences from 44 vaccine and 66 placebo recipients were examined. We show that vaccine-induced immune responses were associated with two signatures in V2 at amino acid positions 169 and 181. Vaccine efficacy against viruses matching the vaccine at position 169 was 48% (confidence interval 18% to 66%; P = 0.0036), whereas vaccine efficacy against viruses mismatching the vaccine at position 181 was 78% (confidence interval 35% to 93%; P = 0.0028). Residue 169 is in a cationic glycosylated region recognized by broadly neutralizing and RV144-derived antibodies. The predicted distance between the two signature sites (21 ± 7 Å) and their match/mismatch dichotomy indicate that multiple factors may be involved in the protection observed in RV144. Genetic signatures of RV144 vaccination in V2 complement the finding of an association between high V1/V2-binding antibodies and reduced risk of HIV-1 acquisition, and provide evidence that vaccine-induced V2 responses plausibly had a role in the partial protection conferred by the RV144 regimen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phylogenies and the Comparative Method
Felsenstein, J. (1985) · The American Naturalist · doi:10.1086/284325 · Cited by 9,793
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Self-citationAntibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Self-citationThe positive false discovery rate: a Bayesian interpretation and the q-value
Storey, J. D. (2003) · The Annals of Statistics · doi:10.1214/aos/1074290335 · Cited by 2,204
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
Self-citationDatamonkey: rapid detection of selective pressure on individual sites of codon alignments
Pond, S. L. K., & Frost, S. D. W. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti320 · Cited by 1,354
The Analysis of Failure Times in the Presence of Competing Risks
Prentice, R. L., Kalbfleisch, J. D., Peterson, A. V., Flournoy, N., Farewell, V. T., & Breslow, N. E. (1978) · Biometrics · doi:10.2307/2530374 · Cited by 1,266
Applying Cox Regression to Competing Risks
Lunn, M., & McNeil, D. (1995) · Biometrics · doi:10.2307/2532940 · Cited by 975
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J.-P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., et al. (2011) · Nature · doi:10.1038/nature10696 · Cited by 830
Self-citationEnvelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission
Derdeyn, C. A., Decker, J. M., Bibollet-Ruche, F., Mokili, J. L., Muldoon, M., Denham, S. A., Heil, M. L., Kasolo, F., Musonda, R., Hahn, B. H., et al. (2004) · Science · doi:10.1126/science.1093137 · Cited by 617
Huey, R. B., Garland, T., & Turelli, M. (2019) · The American Naturalist · doi:10.1086/703055 · Cited by 592
Nomenclature for Immune Correlates of Protection After Vaccination
Plotkin, S. A., & Gilbert, P. B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis238 · Cited by 347
Self-citationComputational characterization of B-cell epitopes
Rubinstein, N. D., Mayrose, I., Halperin, D., Yekutieli, D., Gershoni, J. M., & Pupko, T. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.016 · Cited by 251
Moore, P. L., Ranchobe, N., Lambson, B. E., Gray, E. S., Cave, E., Abrahams, M.-R., Bandawe, G., Mlisana, K., Abdool Karim, S. S., Williamson, C., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000598 · Cited by 233
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
Rolland, M., Tovanabutra, S., deCamp, A. C., Frahm, N., Gilbert, P. B., Sanders-Buell, E., Heath, L., Magaret, C. A., Bose, M., Bradfield, A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2316 · Cited by 225
Self-citationRobb, M. L., Rerks-Ngarm, S., Nitayaphan, S., Pitisuttithum, P., Kaewkungwal, J., Kunasol, P., Khamboonruang, C., Thongcharoen, P., Morgan, P., Benenson, M., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70088-9 · Cited by 216
Self-citationMoore, P. L., Gray, E. S., Sheward, D., Madiga, M., Ranchobe, N., Lai, Z., Honnen, W. J., Nonyane, M., Tumba, N., Hermanus, T., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02658-10 · Cited by 159
Carlson, J. M., Brumme, Z. L., Rousseau, C. M., Brumme, C. J., Matthews, P. C., Kadie, C. M., Mullins, J. I., Walker, B. D., Harrigan, P. R., Goulder, P., et al. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000225 · Cited by 147
Self-citationAn Evolutionary-Network Model Reveals Stratified Interactions in the V3 Loop of the HIV-1 Envelope
Poon, A. F. Y., Lewis, F. I., Pond, S. L. K., & Frost, S. D. W. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030231 · Cited by 114
Gilbert, P. B., Berger, J. O., Stablein, D. M., Becker, S., Essex, M., Hammer, S. M., Kim, J. H., & DeGruttola, V. G. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq152 · Cited by 101
Self-citationDoria‐Rose, N. A., Georgiev, I. S., O'Dell, S. J., Chuang, G., Staupe, R. P., McLellan, J. S., Gorman, J., Pancera, M., Bonsignori, M., Haynes, B. F., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00696-12 · Cited by 82
Self-citationGilbert, P. B., Self, S. G., Rao, M. R., Naficy, A. B., & Clemens, J. D. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00258-4 · Cited by 70
Self-citationLynch, R. M., Rong, R., Boliar, S., Sethi, A., Li, B., Mulenga, J., Allen, S. A., Robinson, J. E., Gnanakaran, S., & Derdeyn, C. A. (2010) · Journal of Virology · doi:10.1128/jvi.02006-10 · Cited by 62
Gilbert, P. B., Self, S. G., & Ashby, M. A. (1998) · Biometrics · doi:10.2307/2533835 · Cited by 58
Self-citationEvaluating Immune Correlates in HIV Type 1 Vaccine Efficacy Trials: What RV144 May Provide
Rolland, M., & Gilbert, P. B. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0240 · Cited by 42
Self-citation
Cited by
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Doria-Rose, N. A., Schramm, C. A., Gorman, J., Moore, P. L., Bhiman, J. N., DeKosky, B. J., Ernandes, M. J., Georgiev, I. S., Kim, H. J., Pancera, M., et al. (2014) · Nature · doi:10.1038/nature13036 · Cited by 709
Self-citationHIV‐1 neutralizing antibodies: understanding nature's pathways
Mascola, J. R., & Haynes, B. F. (2013) · Immunological Reviews · doi:10.1111/imr.12075 · Cited by 475
Yates, N. L., Liao, H.-X., Fong, Y., deCamp, A., Vandergrift, N. A., Williams, W. T., Alam, S. M., Ferrari, G., Yang, Z.-Y., Seaton, K. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007730 · Cited by 450
Self-citationChung, A. W., Ghebremichael, M., Robinson, H., Brown, E., Choi, I., Lane, S., Dugast, A.-S., Schoen, M. K., Rolland, M., Suscovich, T. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007736 · Cited by 406
Self-citationLiao, H.-X., Bonsignori, M., Alam, S. M., McLellan, J. S., Tomaras, G. D., Moody, M. A., Kozink, D. M., Hwang, K.-K., Chen, X., Tsao, C.-Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.011 · Cited by 377
Self-citation
Metadata
- Authors
- Rolland, M., Edlefsen, P. T., Larsen, B. B., Tovanabutra, S., Sanders-Buell, E., Hertz, T., deCamp, A. C., Carrico, C., Menis, S., Magaret, C. A., Ahmed, H., Juraska, M., Chen, L., Konopa, P., Nariya, S., Stoddard, J. N., Wong, K., Zhao, H., Deng, W., Maust, B. S., Bose, M., Howell, S., Bates, A., Lazzaro, M., O’Sullivan, A., Lei, E., Bradfield, A., Ibitamuno, G., Assawadarachai, V., O’Connell, R. J., deSouza, M. S., Nitayaphan, S., Rerks-Ngarm, S., Robb, M. L., McLellan, J. S., Georgiev, I., Kwong, P. D., Carlson, J. M., Michael, N. L., Schief, W. R., Gilbert, P. B., Mullins, J. I., & Kim, J. H.
- Venue
- Nature
- Published
- 2012-09-10
- Volume
- 490
- Issue
- 7420
- Pages
- 417-420
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1966607693
- Cited by
- 417
- References
- 26
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.